ETOPOSIDE - Usual
IND 178172 Commercial
Phase 3 small_molecule active
Quick answer
ETOPOSIDE - Usual for Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active